虾青素在小鼠肾脏缺血再灌注损伤方面的保护作用-东南大学学报医学版

虾青素在小鼠肾脏缺血再灌注损伤方面的保护作用

单位：南京医科大学鼓楼临床医学院泌尿外科, 江苏南京 210008

分类号：R692

出版年·卷·期（页码）：2015·34·第二期（222-225）

摘要：

目的:探讨虾青素(ATX)在小鼠肾脏缺血再灌注(IR)损伤方面的保护作用.方法:将雄性ICR小鼠随机分为4组:假手术组1(Sham)、假手术组2(Sham+ATX)、手术组1(IR)、手术组2(IR+ATX).用灌胃法分别管饲等量ATX(5 mg·kg^-1·d^-1)和橄榄油2周,左肾蒂夹闭50 min诱导IR损伤.收集24 h后血清标本及肾脏组织.比较各组间血尿素氮(BUN)、血肌酐(Cr),肾组织超氧化物歧化酶(SOD)、脂质过氧化产物丙二醇(MDA)含量及肾脏的组织病理学评分.结果:IR+ATX组血清BUN、Cr较IR组显著下降(P <0.05),SOD较IR组明显升高(P <0.05),MDA较IR组明显降低(P <0.05);肾脏组织病理学评分IR+ATX组较IR组显著降低(P <0.05).结论:ATX对肾功能及肾脏组织具有保护作用.

Objective: To investigate the protective effect of astaxanthin(ATX) on ischemia-reperfusion(IR) injury in mice. Methods: The male ICR mice were divided into 4 groups: sham group fed olive oil (Sham), sham group fed astaxanthin (Sham+ATX), surgery group fed olive oil (IR), surgery group fed astaxanthin (IR+ATX). By gavage tube the same amount of astaxanthin (5 mg·kg·d^-1) and olive oil were fed two weeks, the left renal pedicle occlusion 50 min induced renal injury caused by ischemia and reperfusion. Serum samples and kidney tissue were collected after 24 h. Blood urea nitrogen (BUN), creatinine (Cr), superoxide dismutase (SOD), lipid peroxidation products of propylene glycol (MDA) and kidney histopathology score were compared among the groups. Results: Serum BUN, Cr in IR+ATX group were decreased significantly (P <0.05) compared with the IR group. SOD in IR+ATX group was significantly higher than IR group(P <0.05), MDA in IR+ATX group was decreased significantly than IR group(P <0.05). Kidney histopathology rating in IR+ATX group was decreased significantly than IR group(P <0.05). Conclusion: The astaxanthin is effective in preserving renal function and histology via anti-oxidant activity.

参考文献：

[1] STALLONE G,INFANTE B,GESUALDO L,et al.Older donors and older recipients in kidney transplantation[J].J Nephrol,2010,23( Suppl 15):S98-103.
[2] CARDEN D L,GRANGER D N.Pathophysiology of ischaemia-reperfusion injury[J].J Pathol,2000,190:255-266.
[3] DEVARAJAN P.Update on mechanisms of ischemic acute kidney injury[J].J Am Soc Nephrol,2006,17:1503-1520.
[4] PERICO N,CATTANEO D,SAYEGH M H,et al.Delayed graft function in kidney transplantation[J].Lancet,2004,364:1814-1827.
[5] LEE D B,HUANG E,WARD H J.Tight junction biology and kidney dysfunction[J].Am J Physiol Renal Physiol,2006,290:F20-34.
[6] STRUTZ F,ZEISBERG M,ZIYADEH F N,et al.Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation[J].Kidney Int,2002,61:1714-1728.
[7] DRUGAS G T,PAIDAS C N,YAHANDA A M,et al.Conjugated desferoxamine attenuates hepatic microvascular injury following ischemia/reperfusion[J].Circ Shock,1991,34:278-283.
[8] ATALLA S L,TOLEDO-PEREYRA L H,MACKENZIE G H,et al.Influence of oxygen-derived free radical scavengers on ischemic livers[J].Transplantation,1985,40:584-590.
[9] HUSSEIN G,SANKAWA U,GOTO H,et al.Astaxanthin,a carotenoid with potential in human health and nutrition[J].J Nat Prod,2006,69:443-449.
[10] GUERIN M,HUNTLEY M E,OLAIZOLA M.Haematococcus astaxanthin:applications for human health and nutrition[J].Trends Biotechnol,2003,21:210-216.
[11] LIM B P,NAGAO A,TERAO J,et al.Antioxidant activity of xanthophylls on peroxyl radical-mediated phospholipid peroxidation[J].Biochim Biophys Acta,1992,1126:178-184.
[12] CUREK G D,CORT A,YUCEL G,et al.Effect of astaxanthin on hepatocellular injury following ischemia/reperfusion[J].Toxicology,2010,267:147-153.
[13] LU Y P,LIU S Y,SUN H,et al.Neuroprotective effect of astaxanthin on H(2)O(2)-induced neurotoxicity in vitro and on focal cerebral ischemia in vivo[J].Brain Res,2010,1360:40-48.
[14] SHEN H,KUO C C,CHOU J,et al.Astaxanthin reduces ischemic brain injury in adult rats[J].FASEB J,2009,23:1958-1968.
[15] LAUVER D A,LOCKWOOD S F,LUCCHESI B R.Disodium Disuccinate Astaxanthin (Cardax) attenuates complement activation and reduces myocardial injury following ischemia/reperfusion[J].J Pharmacol Exp Ther,2005,314:686-692.
[16] CHEN Y T,YANG C C,ZHEN Y Y,et al.Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia-reperfusion injury[J].Stem Cell Res Ther,2013,4:62.
[17] KURASHIGE M,OKIMASU E,INOUE M,et al.Inhibition of oxidative injury of biological membranes by astaxanthin[J].Physiol Chem Phys Med NMR,1990,22:27-38.
[18] PASHKOW F J,WATUMULL D G,CAMPBELL C L.Astaxanthin:a novel potential treatment for oxidative stress and inflammation in cardiovascular disease[J].Am J Cardiol,2008,101:58D-68D.
[19] FASSETT R G,COOMBES J S.Astaxanthin:a potential therapeutic agent in cardiovascular disease[J].Mar Drugs,2011,9:447-465.
[21] PETRI D,LUNDEBYE A K.Tissue distribution of astaxanthin in rats following exposure to graded levels in the feed[J].Comp Biochem Physiol C Toxicol Pharmacol,2007,145:202-209.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录